Jabra Enhance Select 200 vs RxEars Rxi

The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earns a B grade with a SoundScore of 3.9/5 in our lab testing, ranking in the top 35% of OTC devices. At $1,695, it sits at the higher end of the OTC market and has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. This behind-the-ear device delivers its strongest performance in speech clarity during quiet environments, scoring 3.5/5—a solid result that sits 0.67 points above the OTC category average. Own-voice comfort is another highlight at 3.4/5, which is 0.89 points above average, meaning wearers are less likely to experience the bothersome "talking in a barrel" sensation. Music streaming scores 2.6/5, which is 0.68 points above the category average, though still mixed in absolute terms. The device shows some limitations in challenging listening situations. Speech in noise performance is low at 1.4/5, sitting slightly below the category average. Feedback handling scores a strong 4.0/5 in absolute terms, though this falls 0.54 points below the OTC average of 4.54/5. The Enhance Select 200 includes modern conveniences like rechargeable batteries and streaming compatibility with both iPhone and Android devices, plus hands-free calling capability. However, budget-conscious shoppers should note that several devices in this price range—including the Lucid Tala and Audicus Omni 2—achieve higher scores, and alternatives like the Lucid Engage offer similar sound quality at lower prices. This device is best suited for listeners who prioritize clear speech in quieter settings and natural own-voice quality over performance in noisy environments.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it represents one of the most affordable options in the prescription hearing aid category while still delivering solid overall performance. Speech clarity is a notable strength for this device. In quiet listening environments, the Rxi scores 4.3/5, which is 0.97 points above the category average—a strong result that should benefit users in conversational settings at home or in calm environments. Speech understanding in noisy conditions scores 2.1/5, slightly above the category average by 0.16 points, though this remains mixed in absolute terms and may present challenges in demanding acoustic situations like busy restaurants. Feedback handling is excellent at 4.7/5, essentially matching the category average and indicating reliable stability during daily wear. However, the Rxi shows notable limitations in other areas. Own-voice comfort scores 1.6/5, falling 1.15 points below the category average, which may result in a hollow or boomy perception of your own voice. Music streaming is not supported, scoring 0.0/5—a significant gap of 2.64 points below category average that buyers should consider if streaming audio matters to them. The RxEars Rxi is best suited for budget-conscious consumers who prioritize speech clarity in quieter environments and don't require streaming capabilities. Its invisible form factor and disposable battery design offer convenience, though those seeking better own-voice comfort or music features should explore alternatives.